Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Prolia Revenue	4.41B	4.37B
Prolia Revenue Growth	0.91%	8.05%
ENBREL Revenue	2.23B	3.32B
ENBREL Revenue Growth	-32.87%	-10.31%
XGEVA Revenue	2.08B	2.23B
XGEVA Revenue Growth	-6.34%	5.35%
Repatha Revenue	3.02B	2.22B
Repatha Revenue Growth	35.73%	35.90%
Otezla Revenue	2.27B	2.13B
Otezla Revenue Growth	6.54%	-2.83%
TEPEZZA Revenue	1.90B	1.85B
TEPEZZA Revenue Growth	2.81%	313.17%
EVENITY Revenue	2.10B	1.56B
EVENITY Revenue Growth	34.36%	34.74%
KYPROLIS Revenue	1.41B	1.50B
KYPROLIS Revenue Growth	-6.05%	7.13%
Nplate Revenue	1.52B	1.46B
Nplate Revenue Growth	4.67%	-1.42%
Aranesp Revenue	1.39B	1.34B
Aranesp Revenue Growth	3.50%	-1.47%
BLINCYTO Revenue	1.56B	1.22B
BLINCYTO Revenue Growth	28.21%	41.23%
KRYSTEXXA Revenue	1.34B	1.19B
KRYSTEXXA Revenue Growth	13.08%	335.66%
Vectibix Revenue	1.18B	1.05B
Vectibix Revenue Growth	12.44%	6.20%
TEZSPIRE Revenue	1.48B	972.00M
TEZSPIRE Revenue Growth	52.06%	71.43%
Other Products Revenue	7.26B	5.63B
Other Products Revenue Growth	29.00%	19.89%
Product Revenue	35.15B	32.03B
Product Revenue Growth	9.75%	19.01%
Other Revenue	1.60B	1.40B
Other Revenue Growth	14.66%	9.22%
Revenue (Total)	36.75B	33.42B
Revenue (Total) Growth	9.95%	18.57%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
U.S. Revenue	26.42B	23.86B
U.S. Revenue Growth	10.71%	20.48%
Rest of World (ROW) Revenue	10.33B	9.56B
Rest of World (ROW) Revenue Growth	8.06%	14.04%
Revenue (Total)	36.75B	33.42B
Revenue (Total) Growth	9.95%	18.57%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
McKesson Corporation Revenue	26.25B	22.17B
McKesson Corporation Revenue Growth	18.40%	16.48%
Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue	20.99B	18.39B
Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue Growth	14.13%	10.60%
Cardinal Health, Inc. Revenue	12.56B	11.28B
Cardinal Health, Inc. Revenue Growth	11.39%	15.38%

Updated Feb 3, 2026. Data Source: Fiscal.ai.